OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
OBI’s new software system, Bio-Linked, will be used to match willing blood donors with researchers at OMRF to build a volunteer group for StopRA.
Research yields new information about the life-threatening disease
In the fight against infection, the human immune system isn’t ready for a war. Vaccines push the immune system to create defenses against illness, but they take time to work. A new process developed by scientists at the Oklahoma Medical Research Foundation stands to revolutionize the process. In an advance online publication today in the […]